Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
08/2012
08/16/2012US20120207784 Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine
08/16/2012US20120207755 Cancer
08/16/2012US20120207727 Regulatory T Cells and Their Use in Immunotherapy and Suppression of Autoimmune Responses
08/16/2012US20120207711 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
08/16/2012CA2827082A1 Methods of treating macular edema using antiedema therapeutics
08/16/2012CA2826663A1 Therapeutic agent for diastolic congestive heart failure
08/16/2012CA2824252A1 Improved immunotherapy
08/15/2012EP2486942A1 Compositions comprising azelastine and methods of use thereof
08/15/2012EP2486938A1 Vaccine composition containing synthetic adjuvant
08/15/2012EP2486931A1 Therapeutic agent for influenza virus infectious diseases
08/15/2012EP2485749A1 Methods for the prevention or treatment of heart failure
08/15/2012EP2485746A2 Cytoprotective or therapeutic plant composition
08/15/2012EP2485742A1 Antibiotic formulations providing reduced gastrointentestinal side effects
08/15/2012EP2485595A1 Combination therapy using a beta 3 adrenergic receptor agonist and an antimuscarinic agent
08/15/2012EP2249866B1 Use of an acetylsalicylic acid salt for the treatment of viral infections
08/15/2012EP1931322B1 Ikk inhibitors for the treatment of endometriosis
08/15/2012EP1906912B1 Method for prolonging the life of animals
08/15/2012EP1896077B1 Methods and compositions for the prevention and treatment of inflammatory disease
08/15/2012EP1894567B1 Concomitant pharmaceutical agents and use thereof
08/15/2012EP1741431B1 The combination for treating hyperlipemia
08/15/2012EP1515749B1 Combined use of a modulator of cd3 and a glp-1 compound
08/15/2012EP1420716B1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues
08/15/2012EP1294391B1 Combination of agents for inhibiting transplant rejection
08/15/2012CN202376487U Drug tablet
08/15/2012CN102636626A Compound medicine screening method, obtained medicines and application thereof
08/15/2012CN102631689A Magnetic resonance imaging contrast agent for diagnosis and treatment and preparation method thereof
08/15/2012CN102631677A Pharmaceutical composition for preventing and/or treating atherosclerosis
08/15/2012CN102631344A Nebulizer formulation
08/15/2012CN102631312A Compound antithyroid gel for external application and preparation method thereof
08/15/2012CN102218143B Water dispersion type carbon nano-tube freeze-dried powder and preparation method thereof
08/15/2012CN101816793B Compounds, formulations, and methods for treating or preventing rosacea
08/15/2012CN101815532B Remedy for graft-versus-host disease comprising interleukin-6 receptor inhibitor as the active ingredient
08/15/2012CN101653440B Treatment composition containing amlodipine series salt and pril medicament
08/15/2012CN101203251B 玻璃体可视化剂 Vitreous visualization agent
08/14/2012US8242146 Administering ROFLUMILAS and DICLOFENAC; antiinflammatory agents
08/14/2012US8242115 Materials and methods to potentiate cancer treatment
08/14/2012US8242098 Methods of treating hormone-related conditions using thio-oxindole derivatives
08/14/2012US8242091 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1; peroxiredoxin
08/14/2012US8242079 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
08/14/2012US8241899 Anti-TNF antibodies, compositions, methods and uses
08/14/2012US8241848 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
08/14/2012US8241667 Dual controlled release osmotic device
08/14/2012US8241636 Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
08/14/2012US8241627 Modified polypeptides stabilized in a desired conformation and methods for producing same
08/14/2012US8239978 Vision through photodynamic therapy of the eye
08/14/2012CA2537665C Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
08/14/2012CA2514971C Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene
08/14/2012CA2489705C Use of amide derivative of ge 2270 factor a3 for the treatment of acne
08/14/2012CA2472021C Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps)
08/14/2012CA2452075C Sustained release delivery system
08/14/2012CA2436326C Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
08/09/2012WO2012106287A2 Methods of treating acute kidney injury with retinoc acid
08/09/2012WO2012105625A1 Transdermal absorption-promoting agent and transdermal patch containing same
08/09/2012WO2012105610A1 Medicinal agent for prevention or treatment of diseases associated with intraocular neovascularization and/or intraocular vascular hyperpermeability
08/09/2012WO2012105312A1 Arthritis prevention/amelioration substance
08/09/2012WO2012104846A1 Ras inhibitors for treating diseases or pathological conditions characterized insulin resistance
08/09/2012WO2012104822A1 Combinations comprising macitentan for the treatment of glioblastoma multiforme
08/09/2012WO2012104428A1 (5s,8s)-3-(4'-chlor-3'-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one (compound a) for treatment
08/09/2012WO2012104402A1 Treatment of severe persitent asthma with masitinib
08/09/2012WO2012030309A3 Formulation of comprising tiotropium and a calcium channel blocker
08/09/2012WO2011133964A3 Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
08/09/2012WO2011133790A3 Combination of a serotonin and norepinephrine reuptake inhibitor and an opioid agonist for the treatment of pain
08/09/2012US20120203162 Method for treating neovascularization
08/09/2012US20120202773 Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient
08/09/2012US20120202742 Methods and devices for the sustained release of multiple drugs
08/09/2012US20120202208 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
08/09/2012US20120201818 Treatment of multiple sclerosis
08/09/2012US20120201790 Promoters exhibiting endothelial cell specificity and methods of using same
08/09/2012CA2826515A1 (5s,8s)-3-(4'-chlor-3'-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one (compound a) for treatment
08/09/2012CA2826356A1 Substance for preventing and improving arthritis
08/09/2012CA2823994A1 Combinations comprising macitentan for the treatment of glioblastoma multiforme
08/08/2012EP2484382A1 Medicament comprising a phosphodiesterase IV inhibitor in an inhalable form
08/08/2012EP2484381A1 Composition for a treatment of demyelinating diseases and paralysis by administration of remyelinating agents
08/08/2012EP2484375A2 Vaccine composition containing synthetic adjuvant
08/08/2012EP2484365A1 Compositions and method for treatment of neovascular diseases
08/08/2012EP2484364A1 Compositionas and methods for treatment of neovascular diseases
08/08/2012EP2484363A1 (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-5-methylthiophene-2-carboxamide
08/08/2012EP2482839A1 Means and methods for treating ischemic conditions
08/08/2012EP2482822A1 Orally administered corticosteroid compositions
08/08/2012EP2482806A1 Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
08/08/2012EP2482800A1 Cosmetic foam
08/08/2012EP2482798A1 Olopatadine compositions and uses thereof
08/08/2012EP1910825B1 Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds
08/08/2012EP1690550B1 Therapeutic agent for mesothelioma
08/08/2012EP1458399B1 Pregnane steroids for use in the treatment of cns disorders
08/08/2012EP1169038B1 Cyclic protein tyrosine kinase inhibitors
08/08/2012EP1054664B1 Method for modulating macrophage activation
08/08/2012CN102627676A C-aryl glucoside sglt2 inhibitors and method
08/08/2012CN102627645A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
08/08/2012CN102627609A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors
08/08/2012CN102626518A Preparation and application of insoluble drug-entrapped poloxamer/amphiphilic polysaccharide mixed micelle
08/08/2012CN102626517A Method to modulate hematopoietic stem cell growth
08/08/2012CN102626413A Application of phenoxyl pyridine derivative
08/08/2012CN102626401A Hydrogel paste and preparation method thereof
08/08/2012CN102626393A Albumin nanometer particle preparation for soluble injection and preparation method of albumin nanometer particle preparation
08/08/2012CN102018667B Imidazoles antifungal skin wiping agent and preparation method thereof
08/08/2012CN101961418B Double-controlled release, high-dosage and low-irritation capsaicin compound transdermal patch
08/08/2012CN101757470B Blood fat lowering composition
08/08/2012CN101310771B 视觉功能障碍改善剂 Visual dysfunction improving agent
08/07/2012US8236836 Composition comprising at least one oxazoline for inhibiting langerhans cell migration, and uses thereof
1 ... 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 ... 1151